# Post-ATU Study of Nivolumab

> **NCT03325257** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 350 (actual)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Routine care

## Key facts

- **NCT ID:** NCT03325257
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2018-09-06
- **Final completion:** 2019-03-01
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03325257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03325257, "Post-ATU Study of Nivolumab". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03325257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*